* Acadia Healthcare Company Inc ACHC.OQ ACHC.O is
expected
to show a rise in quarterly revenue when it reports results on
February 27 for the period ending December 31 2023
* The Franklin Tennessee-based company is expected to
report a
7.7% increase in revenue to $727.598 million from $675.3 million
a year ago, according to the mean estimate from 11 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Acadia Healthcare
Company Inc
is for earnings of 79 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Acadia
Healthcare
Company Inc is $90.00, above its last closing price of $84.29.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 0.89 0.89 0.91 Beat 2.2
Jun. 30 2023 0.85 0.86 0.92 Beat 7.5
Mar. 31 2023 0.71 0.71 0.75 Beat 5.8
Dec. 31 2022 0.75 0.75 0.70 Missed -6.6
Sep. 0.79 0.79 1.64 Beat 108.5
30 2022
Jun. 30 2022 0.78 0.78 0.84 Beat 8
Mar. 31 2022 0.64 0.64 0.67 Beat 5.4
Dec. 31 2021 0.68 0.68 0.67 Missed -2
This summary was machine generated February 24 at 03:01 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)